Cassava Leaves (Manihot esculenta)

Cassava leaves (Manihot esculenta) are rich in flavonoids, polyphenols, and rutin, which exert anti-inflammatory and hepatoprotective effects primarily by inhibiting pro-inflammatory enzymes like COX and neutralizing reactive oxygen species. The leaves also contain significant levels of protein, beta-carotene, and cyanogenic glucosides that require proper processing to reduce toxicity before consumption.

Origin & History

Cassava leaves are derived from Manihot esculenta Crantz, a perennial shrub native to South America and widely cultivated in tropical regions of Africa and Asia. The leaves are processed into extracts using methods such as ethanol-water maceration (1:1 v/v), boiling in water, or ethanol maceration (70-95%), yielding nutrient-dense materials rich in flavonoids, tannins, and phenolic compounds.

Historical & Cultural Context

Cassava leaves have been used in traditional medicine systems of tropical regions, particularly in African and Asian folk medicine, for their nutritional value and treatment of inflammation, wounds, liver issues, and infections. The phytochemical properties support their historical role in prophylaxis against oxidative stress and immunomodulation.

Health Benefits

• Anti-inflammatory effects: Preclinical studies show cassava leaf extract inhibits carrageenan-induced paw edema and xylene-induced ear swelling more effectively than indomethacin (10 mg/kg) in rodent models
• Hepatoprotective properties: Animal studies demonstrate ethanol-water extracted cassava leaf flavonoids (100-400 mg/kg) reduce ALT and AST levels in CCl4-induced liver damage in mice
• Wound healing support: Topical application enhanced collagen synthesis and fibroblast proliferation in diabetic rat wound models
• Neuroprotective potential: PMID 37948133 notes prevention of Aβ-related memory deficits in Alzheimer's disease models with leaf extract pretreatment (preclinical evidence only)
• Antioxidant activity: In vitro and animal studies show reduction of oxidative stress markers through flavonoid and phenolic compound content

How It Works

Cassava leaf flavonoids, particularly rutin and quercetin derivatives, inhibit cyclooxygenase (COX-1 and COX-2) enzymes and suppress NF-κB signaling, reducing downstream synthesis of prostaglandins and pro-inflammatory cytokines such as TNF-α and IL-6. The polyphenolic constituents scavenge reactive oxygen species and upregulate endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase, protecting hepatocytes from oxidative stress-induced apoptosis. Additionally, cyanogenic glucosides such as linamarin and lotaustralin are metabolized to hydrogen cyanide upon improper preparation, necessitating heat and water processing to hydrolyze these compounds to safe levels.

Scientific Research

Current evidence is limited to preclinical in vivo animal studies and in vitro assays, with no human clinical trials, randomized controlled trials, or meta-analyses identified. Studies include hepatoprotection in ICR mice (18-22g), anti-inflammatory effects in Sprague-Dawley rats (150-200g), and neuroprotection in Alzheimer's disease models (PMID 37948133).

Clinical Summary

The majority of evidence for cassava leaf benefits comes from preclinical rodent studies; ethanol-water extracts have demonstrated inhibition of carrageenan-induced paw edema and xylene-induced ear swelling at doses outperforming indomethacin at 10 mg/kg in mouse models. Animal hepatoprotection studies show that cassava leaf extract significantly reduces serum ALT and AST levels in paracetamol-induced liver injury models, suggesting preservation of hepatocyte membrane integrity. Human clinical trials are largely absent from the peer-reviewed literature, limiting the ability to extrapolate preclinical findings to therapeutic dosing in people. Nutritional studies in sub-Saharan African and Southeast Asian populations document cassava leaves as a meaningful dietary source of protein (up to 7g/100g fresh weight) and beta-carotene, though bioavailability data remain sparse.

Nutritional Profile

Per 100 g of raw cassava leaves: Protein 6.8–7.0 g (notably high for a leafy vegetable; contains all essential amino acids, though methionine is limiting); Fat 1.3–1.8 g; Carbohydrates 13–15 g; Dietary fiber 2.4–4.0 g; Energy ~91–100 kcal. Vitamins: Vitamin C 60–275 mg (highly variable by cultivar and preparation; significant losses of 40–70% occur during boiling/pounding required to remove cyanogenic glycosides); Vitamin A as β-carotene 8,300–11,000 µg (retinol activity equivalent ~830–1,100 µg RAE; bioavailability enhanced by co-consumption with dietary fat); Vitamin B1 (thiamine) 0.16–0.25 mg; Vitamin B2 (riboflavin) 0.32–0.60 mg; Niacin (B3) 1.5–2.4 mg; Folate (B9) ~120–165 µg; Vitamin K ~108 µg. Minerals: Calcium 160–303 mg (bioavailability reduced by co-present oxalates); Iron 3.6–7.6 mg (predominantly non-heme; absorption improved by concurrent vitamin C intake); Magnesium 51–68 mg; Phosphorus 68–112 mg; Potassium 350–520 mg; Zinc 1.1–2.0 mg; Manganese 3.0–4.2 mg. Bioactive compounds: Cyanogenic glycosides (linamarin 80–95% and lotaustralin 5–20% of total; raw leaf concentration 200–1,340 mg HCN equivalents/kg dry weight — proper processing via crushing, soaking, and prolonged boiling reduces to safe levels <10 mg/kg); Flavonoids including rutin (quercetin-3-O-rutinoside, 12–38 mg/100 g dry weight), kaempferol glycosides, and apigenin derivatives; Phenolic acids including chlorogenic acid, caffeic acid, and ferulic acid (total phenolics ~1,200–2,800 mg GAE/100 g dry weight); Condensed tannins 0.4–2.5 g/100 g dry weight (reduce protein digestibility by 5–15%); Saponins (triterpenoid type, moderate concentrations); Phytic acid 0.3–0.6 g/100 g (chelates divalent minerals, reducing Zn and Fe bioavailability by ~20–40%); Oxalates 120–260 mg/100 g fresh weight. The leaves are considered one of the most protein-dense tropical leafy vegetables; lysine content is particularly high (~5.5–7.0 g/100 g protein), making them complementary to cereal-based diets. Essential fatty acid profile includes α-linolenic acid (omega-3) constituting ~40–55% of total fatty acids, though absolute lipid content is low. Prolonged boiling (the standard preparation method to ensure cyanide detoxification) reduces vitamin C by 50–70%, β-carotene by 15–30%, and soluble minerals by 20–40%, but is necessary for safe consumption.

Preparation & Dosage

Preclinical studies used: ethanol-water flavonoid extract at 100-400 mg/kg body weight orally in mice; boiled water extract at 100-400 mg/kg orally or 1-4% w/w topically in rats/mice; ethanol extracts at 200 µg/mL in vitro. No human dosage data available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, turmeric, green tea extract, alpha-lipoic acid, quercetin

Safety & Interactions

Raw or improperly processed cassava leaves contain cyanogenic glucosides (linamarin, lotaustralin) that release hydrogen cyanide upon hydrolysis; chronic low-level cyanide exposure is linked to konzo, an irreversible spastic paralysis, particularly in malnourished populations. Boiling, soaking, or fermenting leaves significantly reduces cyanide content to below the WHO threshold of 10 mg HCN equivalents per 100g fresh weight. Cassava leaf extracts may potentiate the effects of anticoagulant drugs such as warfarin due to rutin's vitamin K antagonism activity, and individuals on hepatotoxic medications should exercise caution given the extract's influence on liver enzyme metabolism. Pregnant and breastfeeding women should avoid concentrated extracts due to insufficient safety data, though traditionally prepared cooked leaves consumed as food are generally considered safe in moderate dietary amounts.